{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:26:44Z","timestamp":1792121204973,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05133-5","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T09:00:44Z","timestamp":1760086844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of continuation vs. interruption of anticoagulation during transcatheter aortic valve implantation: A systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Umar G.","family":"Adamu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marheb","family":"Badianyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupa","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Mutyaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nqoba","family":"Tsabedze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"issue":"7","key":"5133_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561\u2013632. https:\/\/doi.org\/10.1093\/eurheartj\/ehab395.","journal-title":"Eur Heart J"},{"issue":"24","key":"5133_CR2","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1016\/j.jcin.2023.10.011","volume":"16","author":"AC van Nieuwkerk","year":"2023","unstructured":"van Nieuwkerk AC, Aarts HM, Hemelrijk KI, Cant\u00f3n T, Tch\u00e9tch\u00e9 D, de Brito FS Jr, et al. Bleeding in patients undergoing transfemoral transcatheter aortic valve replacement: incidence, trends, clinical outcomes, and predictors. JACC Cardiovasc Interv. 2023;16(24):2951\u201362. https:\/\/doi.org\/10.1016\/j.jcin.2023.10.011.","journal-title":"JACC Cardiovasc Interv"},{"issue":"17","key":"5133_CR3","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/eurheartj\/ehw456","volume":"38","author":"G Tarantini","year":"2017","unstructured":"Tarantini G, Mojoli M, Urena M, Vahanian A. Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome. Eur Heart J. 2017;38(17):1285\u201393. https:\/\/doi.org\/10.1093\/eurheartj\/ehw456.","journal-title":"Eur Heart J"},{"issue":"18","key":"5133_CR4","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1056\/NEJMoa1200384","volume":"366","author":"SK Kodali","year":"2012","unstructured":"Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366(18):1686\u201395. https:\/\/doi.org\/10.1056\/NEJMoa1200384.","journal-title":"N Engl J Med"},{"issue":"5","key":"5133_CR5","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","volume":"162","author":"JD Douketis","year":"2022","unstructured":"Douketis JD, Spyropoulos AC, Murad MH, Arcelus JI, Dager WE, Dunn AS, et al. Perioperative management of antithrombotic therapy: an American college of chest physicians clinical practice guideline. Chest. 2022;162(5):e207\u201343. https:\/\/doi.org\/10.1016\/j.chest.2022.07.025.","journal-title":"Chest"},{"issue":"16","key":"5133_CR6","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","volume":"39","author":"JD Douketis","year":"2018","unstructured":"Douketis JD, Spyropoulos AC, Murad MH, Arcelus JI, Dager WE, Dunn AS, ESC Scientific Document Group, et al. The 2018 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39(16):1330\u201393. https:\/\/doi.org\/10.1093\/eurheartj\/ehy136.","journal-title":"Eur Heart J"},{"issue":"15","key":"5133_CR7","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.jacc.2018.11.066","volume":"73","author":"M Brinkert","year":"2019","unstructured":"Brinkert M, Keller LS, Moriyama N, Cuculi F, Bossard M, Lehnick D, et al. Safety and efficacy of transcatheter aortic valve replacement with continuation of oral anticoagulation. J Am Coll Cardiol. 2019;73(15):2004\u20135. https:\/\/doi.org\/10.1016\/j.jacc.2018.11.066.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"5133_CR8","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.amjcard.2018.12.042","volume":"123","author":"N Mangner","year":"2019","unstructured":"Magner N, Crusius L, Haussig S, Woitek FJ, Kiefer P, Stachel G, et al. Continued versus interrupted oral anticoagulation during transfemoral transcatheter aortic valve implantation and impact of postoperative anticoagulant management on outcome in patients with atrial fibrillation. Am J Cardiol. 2019;123(7):1134\u201341. https:\/\/doi.org\/10.1016\/j.amjcard.2018.12.042","journal-title":"Am J Cardiol"},{"issue":"2","key":"5133_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jcin.2020.09.062","volume":"14","author":"M Brinkert","year":"2021","unstructured":"Brinkert M, Mangner N, Moriyama N, Keller LS, Hagemeyer D, Crusius L, et al. Safety and efficacy of transcatheter aortic valve replacement with continuation of vitamin K antagonists or direct oral anticoagulants. JACC Cardiovasc Interv. 2021;14(2):135\u201344. https:\/\/doi.org\/10.1016\/j.jcin.2020.09.062.","journal-title":"JACC Cardiovasc Interv"},{"key":"5133_CR10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2407794","author":"DJ van Ginkel","year":"2024","unstructured":"van Ginkel DJ, Bor WL, Aarts HM, Dubois C, De Backer O, Rooijakkers MJP, et al. POPular PAUSE TAVI investigators. Continuation versus interruption of oral anticoagulation during TAVI. N Engl J Med. 2024. https:\/\/doi.org\/10.1056\/NEJMoa2407794.","journal-title":"N Engl J Med"},{"issue":"12","key":"5133_CR11","doi-asserted-by":"publisher","first-page":"e76434","DOI":"10.7759\/cureus.76434","volume":"16","author":"G Tabowei","year":"2024","unstructured":"Tabowei G, Dadzie SK, Ahzam RM, Rehman MM, Blair K, Habib I, et al. Continuation versus interruption of anticoagulation during transcatheter aortic valve implantation: a systematic review and meta-analysis. Cureus. 2024;16(12):e76434. https:\/\/doi.org\/10.7759\/cureus.76434.","journal-title":"Cureus"},{"key":"5133_CR12","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372. https:\/\/doi.org\/10.1136\/BMJ.N71.","DOI":"10.1136\/BMJ.N71"},{"key":"5133_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019. https:\/\/doi.org\/10.1136\/BMJ.","journal-title":"BMJ"},{"issue":"5","key":"5133_CR14","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/ehjcvp\/pvad101","volume":"10","author":"JA Sterne","year":"2024","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. Antithrombotic therapy in patients after transcatheter aortic valve implantation: A network meta-analysis. Eur Heart J- Cardiovasc Pharmacoth. 2024;10(5):454\u201364. https:\/\/doi.org\/10.1093\/ehjcvp\/pvad101.","journal-title":"Eur Heart J- Cardiovasc Pharmacoth"},{"issue":"1","key":"5133_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4244\/EIJV8I1A20","volume":"8","author":"H Eggebrecht","year":"2012","unstructured":"Eggebrecht H, Schmermund A, Voigtl\u00e4nder T, Kahlert P, Erbel R, Mehta RH. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention. 2012;8(1):129\u201338. https:\/\/doi.org\/10.4244\/EIJV8I1A20.","journal-title":"EuroIntervention"},{"issue":"12","key":"5133_CR16","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/clc.22328","volume":"37","author":"I Mastoris","year":"2014","unstructured":"Mastoris I, Schoos MM, Dangas GD, Mehran R. Stroke after transcatheter aortic valve replacement: incidence, risk factors, prognosis, and preventive strategies. Clin Cardiol. 2014;37(12):756\u201364. https:\/\/doi.org\/10.1002\/clc.22328.","journal-title":"Clin Cardiol"},{"issue":"1","key":"5133_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/heartjnl-2011-300065","volume":"98","author":"TA Fairbairn","year":"2012","unstructured":"Fairbairn TA, Mather AN, Bijsterveld P, Worthy G, Currie S, Goddard AJ, et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart. 2012;98(1):18\u201323. https:\/\/doi.org\/10.1136\/heartjnl-2011-300065.","journal-title":"Heart"},{"issue":"25","key":"5133_CR18","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.jacc.2013.03.029","volume":"62","author":"J Rod\u00e9s-Cabau","year":"2013","unstructured":"Rod\u00e9s-Cabau J, Dauerman HL, Cohen MG, Mehran R, Small EM, Smyth SS, et al. Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. J Am Coll Cardiol. 2013;62(25):2349\u201359. https:\/\/doi.org\/10.1016\/j.jacc.2013.03.029.","journal-title":"J Am Coll Cardiol"},{"key":"5133_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejim.2022.05.002","volume":"101","author":"DJ van Ginkel","year":"2022","unstructured":"van Ginkel DJ, Bor WL, Veenstra L, van \u2018t Hof AWJ, Fabris E. Evolving concepts in the management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation. Eur J Intern Med. 2022;101:14\u201320. https:\/\/doi.org\/10.1016\/j.ejim.2022.05.002.","journal-title":"Eur J Intern Med"},{"issue":"4","key":"5133_CR20","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.amjcard.2017.05.035","volume":"120","author":"Y Sun","year":"2017","unstructured":"Sun Y, Liu X, Chen Z, Fan J, Jiang J, He Y, et al. Meta-analysis of predictors of early severe bleeding in patients who underwent transcatheter aortic valve implantation. Am J Cardiol. 2017;120(4):655\u201361.","journal-title":"Am J Cardiol"},{"issue":"4","key":"5133_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1056\/NEJMoa022831","volume":"349","author":"A Vincentelli","year":"2003","unstructured":"Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med. 2003;349(4):343\u20139. https:\/\/doi.org\/10.1056\/NEJMoa022831.","journal-title":"N Engl J Med"},{"issue":"1","key":"5133_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.21470\/1678-9741-2021-0331","volume":"38","author":"MA Albabtain","year":"2023","unstructured":"Albabtain MA, Arafat AA, Alghasoon H, Abdelsalam W, Almoghairi A, Alotaiby M. HAS-BLED score for prediction of bleeding and mortality after transcatheter aortic valve replacement. Braz J Cardiovasc Surg. 2023;38(1):37\u201342. https:\/\/doi.org\/10.21470\/1678-9741-2021-0331.","journal-title":"Braz J Cardiovasc Surg"},{"issue":"1","key":"5133_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/ehjcvp\/pvz064","volume":"7","author":"JH Butt","year":"2021","unstructured":"Butt JH, De Backer O, Olesen JB, Gerds TA, Havers-Borgersen E, Gislason GH, et al. Vitamin K antagonists vs. direct oral anticoagulants after transcatheter aortic valve implantation in atrial fibrillation. Eur Heart J. 2021;7(1):11\u20139. https:\/\/doi.org\/10.1093\/ehjcvp\/pvz064.","journal-title":"Eur Heart J"},{"issue":"22","key":"5133_CR24","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1016\/j.jcin.2020.09.013","volume":"13","author":"H Kawashima","year":"2020","unstructured":"Kawashima H, Watanabe Y, Hioki H, Kozuma K, Kataoka A, Nakashima M, et al. Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after TAVR. JACC Cardiovasc Interv. 2020;13(22):2587\u201397. https:\/\/doi.org\/10.1016\/j.jcin.2020.09.013.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"5133_CR25","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3390\/jcm9061621","volume":"9","author":"V Russo","year":"2020","unstructured":"Russo V, Attena E, Rago A, Melillo E, Di Micco P, Papa AA, et al. Clinical outcome of Edoxaban vs. Vitamin K antagonists in patients with atrial fibrillation and diabetes mellitus: results from a multicenter, Propensity-Matched, Real-World cohort study. J Clin Med. 2020;9(6):1621. https:\/\/doi.org\/10.3390\/jcm9061621.","journal-title":"J Clin Med"},{"key":"5133_CR26","doi-asserted-by":"publisher","first-page":"107602962311585","DOI":"10.1177\/10760296231158585","volume":"J","author":"WC Lee","year":"2023","unstructured":"Lee WC, Shih JY, Fang HY, Wu PJ, Fang CY, Chen HC, et al. Comparing vitamin K antagonists and direct oral anticoagulants in patients with atrial fibrillation undergoing transcatheter aortic valve replacement: A Meta-Analysis. Clin Appl Thromb Hemost. 2023;J:10760296231158585. https:\/\/doi.org\/10.1177\/10760296231158585.","journal-title":"Clin Appl Thromb Hemost"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05133-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05133-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05133-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T09:00:44Z","timestamp":1760086844000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-05133-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5133"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05133-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"734"}}